2026 Q1 Portfolio Activity
In 2026 Q1, ADAR1 Capital Management, LLC maintained a portfolio of 350 distinct positions. The most significant new addition was BEAM THERAPEUTICS INC, now representing 2.03% of the total fund value. They heavily accumulated shares in DENALI THERAPEUTICS INC, increasing the position by 3490.9%. The fund also reduced its exposure to ABIVAX SA by 96.7%.
Position History
hover any row below to update
Loading…
Total Positions
350
Quarter
2026 Q1
Top Holding
ABVX (9.1%)
Top 10 Concentration
39.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 350
ADAR1 Capital Management, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA
|
Healthcare | 9.14% | 12.86% |
#1
Prev: #1
|
7.7 |
—
|
76,690 | 5.8% |
P
S
|
1,394,019 | $155,224,016 |
$39.49
+190.0%
|
2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | ||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 6.17% | 6.63% |
#2
Prev: #2
|
4.5 |
—
|
-55,049 | -5.2% |
P
S
|
994,119 | $104,780,143 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 5.36% | 5.39% |
#3
Prev: #3
|
3.6 |
—
|
-143,056 | -4.2% |
P
S
|
3,285,906 | $91,019,596 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 3.92% | 4.57% |
#4
Prev: #4
|
4.1 |
—
|
198,042 | 8.0% |
P
S
|
2,679,010 | $66,546,608 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
SPY
STATE STR SPDR ...
|
ETF | 2.91% | 2.70% |
#5
2
Prev: #7
|
4.2 |
—
|
21,256 | 38.9% |
P
S
|
75,940 | $49,386,820 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 2.84% | 1.58% |
#6
7
Prev: #13
|
4.1 |
—
|
373,084 | 68.9% |
P
S
|
914,699 | $48,222,931 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.45% | 2.49% |
#7
1
Prev: #8
|
3.0 |
—
|
92,390 | 17.1% |
P
S
|
632,556 | $41,691,766 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 2.44% | 1.04% |
#8
13
Prev: #21
|
4.0 |
—
|
829,963 | 268.3% |
P
S
|
1,139,331 | $41,380,502 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
BOXX
EA SERIES TRUST
|
Unknown | 2.31% | 2.81% |
#9
3
Prev: #6
|
1.9 |
—
|
no change | no change |
P
S
|
337,125 | $39,204,266 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 2.12% | 0.06% |
#10
132
Prev: #142
|
3.8 |
—
|
1,819,339 | 3490.9% |
P
S
|
1,871,455 | $35,931,936 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 2.03% | — |
#11
Prev: #—
|
4.3 |
—
|
1,446,375 | — |
NEW
|
1,446,375 | $34,467,116 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 1.58% | 1.59% |
#12
Prev: #12
|
2.6 |
—
|
178,847 | 14.3% |
P
S
|
1,425,367 | $26,811,153 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 1.54% | 2.34% |
#13
4
Prev: #9
|
1.1 |
—
|
-67,793 | -5.9% |
P
S
|
1,089,818 | $26,188,327 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 1.45% | — |
#14
Prev: #—
|
4.1 |
—
|
2,744,714 | — |
NEW
|
2,744,714 | $24,592,637 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 1.25% | — |
#15
Prev: #—
|
4.0 |
—
|
1,012,866 | — |
NEW
|
1,012,866 | $21,158,771 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 1.24% | 0.45% |
#16
33
Prev: #49
|
3.5 |
—
|
2,550,355 | 205.9% |
P
S
|
3,789,132 | $21,029,683 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 1.23% | 0.10% |
#17
100
Prev: #117
|
3.5 |
—
|
390,197 | 2601.3% |
P
S
|
405,197 | $20,900,061 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.18% | 0.22% |
#18
60
Prev: #78
|
3.5 |
—
|
337,684 | 485.3% |
P
S
|
407,273 | $20,021,541 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.08% | 0.40% |
#19
36
Prev: #55
|
3.4 |
—
|
160,101 | 311.8% |
P
S
|
211,450 | $18,389,807 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.00% | 0.08% |
#20
105
Prev: #125
|
3.4 |
—
|
304,272 | 893.6% |
P
S
|
338,323 | $17,065,012 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.94% | 1.29% |
#21
7
Prev: #14
|
0.9 |
—
|
-772,579 | -18.5% |
P
S
|
3,410,190 | $16,027,893 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
PRTA
PROTHENA CORP P...
|
Healthcare | 0.90% | 1.01% |
#22
1
Prev: #23
|
2.4 |
—
|
123,679 | 8.5% |
P
S
|
1,581,443 | $15,371,626 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
SNY
SANOFI SA
|
Healthcare | 0.90% | 0.22% |
#23
54
Prev: #77
|
3.4 |
—
|
253,465 | 399.3% |
P
S
|
316,939 | $15,270,121 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 0.89% | 1.05% |
#24
4
Prev: #20
|
0.9 |
—
|
-56,505 | -17.9% |
P
S
|
259,137 | $15,058,451 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
MNPR
MONOPAR THERAPE...
|
Healthcare | 0.85% | 1.11% |
#25
6
Prev: #19
|
2.3 |
—
|
30,370 | 13.0% |
P
S
|
264,278 | $14,479,792 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
ABUS
ARBUTUS BIOPHAR...
|
Healthcare | 0.83% | 1.89% |
#26
16
Prev: #10
|
0.3 |
—
|
-2,281,934 | -42.1% |
P
S
|
3,133,175 | $14,099,288 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.82% | 0.78% |
#27
6
Prev: #33
|
2.3 |
—
|
110,248 | 12.4% |
P
S
|
1,000,604 | $13,908,396 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.80% | 1.27% |
#28
13
Prev: #15
|
0.3 |
—
|
-218,951 | -33.9% |
P
S
|
427,816 | $13,570,324 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.78% | 0.99% |
#29
4
Prev: #25
|
2.3 |
—
|
483,620 | 19.4% |
P
S
|
2,979,429 | $13,318,048 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.78% | 0.66% |
#30
8
Prev: #38
|
2.3 |
—
|
24,930 | 12.2% |
P
S
|
228,899 | $13,310,477 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.77% | 0.06% |
#31
124
Prev: #155
|
3.3 |
—
|
457,364 | 681.8% |
P
S
|
524,441 | $13,063,825 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.77% | 0.84% |
#32
Prev: #32
|
0.8 |
—
|
-11,186 | -7.7% |
P
S
|
133,893 | $13,021,094 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.76% | 0.03% |
#33
155
Prev: #188
|
3.3 |
—
|
299,540 | 998.5% |
P
S
|
329,540 | $12,917,968 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.74% | 0.78% |
#34
Prev: #34
|
0.3 |
—
|
-72,440 | -28.1% |
P
S
|
185,699 | $12,568,108 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
BIL
SPDR SERIES TRU...
|
ETF | 0.73% | 0.90% |
#35
6
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
135,585 | $12,425,009 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.71% | 0.90% |
#36
8
Prev: #28
|
2.8 |
—
|
42,051 | 24.5% |
P
S
|
213,473 | $12,120,997 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.71% | 0.87% |
#37
7
Prev: #30
|
2.8 |
—
|
341,665 | 27.5% |
P
S
|
1,582,987 | $12,109,851 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.71% | 0.91% |
#38
11
Prev: #27
|
0.8 |
—
|
-535,448 | -19.8% |
P
S
|
2,174,398 | $12,067,909 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.71% | 0.84% |
#39
8
Prev: #31
|
2.3 |
—
|
13,208 | 9.0% |
P
S
|
160,338 | $12,039,780 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.68% | 0.22% |
#40
39
Prev: #79
|
3.3 |
—
|
89,221 | 123.9% |
P
S
|
161,252 | $11,602,081 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 0.65% | 1.20% |
#41
24
Prev: #17
|
0.8 |
—
|
-1,457,377 | -18.1% |
P
S
|
6,606,572 | $11,099,041 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.64% | 0.31% |
#42
22
Prev: #64
|
3.3 |
—
|
991,967 | 268.4% |
P
S
|
1,361,536 | $10,933,134 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
TERN
CALL
TERNS PHARMACEU...
|
CALL Option | 0.62% | — |
#43
Prev: #—
|
3.7 |
—
|
200,000 | — |
NEW
|
200,000 | $10,544,000 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
N/A
HELIX ACQUISITI...
|
|
Unknown | 0.61% | — |
#44
Prev: #—
|
3.7 |
—
|
1,000,000 | — |
NEW
|
1,000,000 | $10,300,000 | — | 13F Filing | 2026-03-31 | 2026-05-18 | ||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 0.59% | 0.51% |
#45
1
Prev: #44
|
2.2 |
—
|
259,113 | 6.0% |
P
S
|
4,544,113 | $10,087,931 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 0.59% | 0.21% |
#46
36
Prev: #82
|
3.2 |
—
|
1,420,783 | 140.1% |
P
S
|
2,434,941 | $10,080,656 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.55% | 0.67% |
#47
10
Prev: #37
|
0.7 |
—
|
103 | 0.9% |
P
S
|
12,154 | $9,390,667 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.50% | — |
#48
Prev: #—
|
3.7 |
—
|
457,137 | — |
NEW
|
457,137 | $8,521,034 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 0.50% | 1.00% |
#49
25
Prev: #24
|
2.2 |
—
|
74,189 | 5.3% |
P
S
|
1,467,350 | $8,422,589 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
IRD
OPUS GENETICS I...
|
Healthcare | 0.50% | 0.01% |
#50
208
Prev: #258
|
3.2 |
—
|
1,809,004 | 4522.5% |
P
S
|
1,849,004 | $8,412,968 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 |
Showing 1-50 of 350 holdings